Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CVSI Annual Report: questions Company's viability
From CV Sciences' 2023 Annual Report dated March 29, 2024:
HELLO! CVSI-007 CONTAINS NICOTINE
Why no investor interest in CVSI-007?
This November 2020 article might help to explain and why that lack of interest is not likely to change.
Why no investor interest in CVSI-007?
This November 2020 article might help to explain and why that lack of interest is not likely to change.
DANGLING CVSI-007 in_front_of investors for YEARS.
For at least SIX(6) YEARS !
and MAJOR DILUTION described in DEF14A - 04/11/2023
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171565189
TOUTING WORTHLESS CVSI-007 to investors
for at least SIX(6) YEARS !
CVSI-007 is easily replaced by inexpensive OTC alternatives. For example:
1. A piece of generic 4mg NICOTINE GUM. (220 pieces for $42), along with
2. One(1) or more of my favorite 25mg CBD GUMMIES. (60 for $56)
VOILA! A chewable combination of nicotine and CBD, available right now!
And, by varying the NICOTINE-GUM-to-GUMMIE RATIO, I can adjust the dosage to my PERSONAL REQUIREMENTS, an option that is NOT POSSIBLE with a fixed-ratio product, like CVSI-007.
There is NO UNDER-SERVED MARKET for a prescription product such as CVSI-007. Look at the "Claims" section of CV Sciences' Japanese patent document:
CVSI-007 and Its Patent are WORTHLESS.
There is NO UNDER-SERVED MARKET for CVSI-007 !
Look at the "Claims" section in the Japanese patent description:
CVSI-007 is easily replaced by inexpensive OTC alternatives:
1. A piece of generic 4mg NICOTINE GUM. (220 pieces for $42)
along with
2. One(1) or more of my favorite 25mg CBD GUMMIES. (60 for $56)
VOILA! A chewable combination of nicotine and CBD, available right now. NO PRESCRIPTION REQUIRED.
And, by varying the NICOTINE-GUM-to-GUMMIE RATIO, I can adjust the dosage to my PERSONAL REQUIREMENTS, an option that is NOT POSSIBLE with a fixed-ratio product, like CVSI-007.
Analyst Community interest in CVSI FY2022??
2022 Q4/Year-End Conference Call -- Voice and Transcript
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171565189
CV Sciences' FY2022 OMG !
CV Sciences' FY2022 Press Release
CVSI has been on a decline for years.
Only "SHARES OUTSTANDING" is increasing, i.e., DILUTION :
CV Sciences
STOCKHOLDER SHARES
REVENUES CASH EQUITY OUTSTANDING
( $M ) ( $M ) ( $M ) ( M )
2018
Q2 12.3 7.2 21.8 90.9
Q3 13.6 11.0 25.8 94.6
Q4 14.2 12.7 30.1 94.9
2019
Q1 14.9 13.6 30.9 98.5
Q2 16.9 15.7 34.3 98.7
Q3 12.6 14.2 33.2 98.8
Q4 9.4 9.6 29.1 99.4
2020
Q1 8.3 7.6 25.4 99.9
Q2 5.4 8.1 * 22.0 99.9
Q3 5.6 6.1 * 19.4 100.0
Q4 5.2 4.5 * 11.2 100.7
2021
Q1 4.8 5.7 * 12.0 106.8
Q2 5.1 3.0 * 10.0 108.5
Q3 5.1 1.7 * 11.1 109.9
Q4 5.0 1.4 * 3.5 112.5
^
Stockholder Equity
Reduced by ~70% in one quarter.
2022
Q1** 4.4 2.4 * 4.0 122.8
Q2** 4.1 1.1 * 1.9 140.0
Q3** 3.8 1.1 * 1.4 150.1
Q4** 3.9 0.6 * (0.8) 152.1
* INCLUDES PPP$2.9M "LOAN", i.e., FEDERAL CHARITY, forgiven in FY2021 Q3.
** Includes $2.0M MORE FEDERAL CHARITY (Employee Retention Credit) under the CARES Act.
CV Sciences' Prelude to FY2022 Report LOL
CV Sciences' FY2022Q3 10-Q
CVSI has been on a decline for years.
Only "SHARES OUTSTANDING" is increasing, i.e., DILUTION :
CV Sciences
STOCKHOLDER SHARES
REVENUES CASH EQUITY OUTSTANDING
( $M ) ( $M ) ( $M ) ( M )
2018
Q2 12.3 7.2 21.8 90.9
Q3 13.6 11.0 25.8 94.6
Q4 14.2 12.7 30.1 94.9
2019
Q1 14.9 13.6 30.9 98.5
Q2 16.9 15.7 34.3 98.7
Q3 12.6 14.2 33.2 98.8
Q4 9.4 9.6 29.1 99.4
2020
Q1 8.3 7.6 25.4 99.9
Q2 5.4 8.1 * 22.0 99.9
Q3 5.6 6.1 * 19.4 100.0
Q4 5.2 4.5 * 11.2 100.7
2021
Q1 4.8 5.7 * 12.0 106.8
Q2 5.1 3.0 * 10.0 108.5
Q3 5.1 1.7 * 11.1 109.9
Q4 5.0 1.4 * 3.5 112.5
^
Stockholder Equity
Reduced by ~70% in one quarter.
2022
Q1** 4.4 2.4 * 4.0 122.8
Q2** 4.1 1.1 * 1.9 140.0
Q3** 3.8 1.1 * 1.4 150.1
* INCLUDES PPP$2.9M "LOAN", i.e., FEDERAL CHARITY, forgiven in FY2021 Q3.
** Includes $2.0M MORE FEDERAL CHARITY (Employee Retention Credit) under the CARES Act.
Why no investor interest in CVSI-007?
This November 2020 article might help to explain and why that lack of interest is not likely to change.
That CVSI-007 Patent is WORTHLESS.
There's NO UNSERVED MARKET !
Look at the "Claims" section in the Japanese patent description:
CVSI-007 is easily replaced NOW by inexpensive OTC alternatives: a piece of generic nicotine gum and 1 or 2 CBD gummies.
If I wanted to "cease" using my favorite "chaw" RIGHT NOW!
and I wanted to use a chewable combination of nicotine and CBD:
First, I'd pop a piece of NICOTINE GUM. (220 pieces for $42)
Then, I'd add 1 or 2 of my favorite CBD GUMMIES. (60 for $56)
VOILA! A chewable combination of nicotine and CBD.
And, by varying the NICOTINE-GUM-to-GUMMIE RATIO, I can adjust the dosage to my PERSONAL REQUIREMENTS, an option that is NOT POSSIBLE with a fixed-ratio product, like CVSI-007.
DANGLING CVSI-007 in front of investors.
For at least SIX(6) YEARS !
Just an FYI
The following is a copy of a post of mine that was deleted from the Ripple(XRP) board yesterday, along with rest of that particular exchange. I was responding to and supporting Dogger05 who was responding to posts from the well-known "douche" who claimed he never "told anyone to buy XRP". Although the douche's "advice" I cited was for XRdoge, it was posted on the XRP board as part of a rather lengthy set of messages dealing with XRdoge.
I thought you might be able to use the info contained in my now-deleted post:
=====================================
I look at these times as a CULLING.
Companies, like Charlotte's Web, with innovative leadership and financial backing will survive.
Old, tired companies, like CV Sciences, that developed corporate culture when they faced no competition will fade away.
FDIC Bailout for SVB Depositors
https://www.barrons.com/articles/svb-depositors-bailout-fdic-fed-db7cfda0
Why should ANYONE INVEST in CV SCIENCES??
GIVEN:
1. Its PERFORMANCE as a STOCK:
but, MORE IMPORTANTLY,
2. Its PERFORMANCE as a BUSINESS:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=170657983
"The CBD gold rush is over" . . . for CV Sciences.
Why should ANYONE INVEST in CV SCIENCES??
GIVEN:
1. Its PERFORMANCE as a STOCK:
but, MORE IMPORTANTLY,
2. Its PERFORMANCE as a BUSINESS:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=170657983
"The CBD gold rush is over" . . . for CV Sciences.
MULTIPLE ANALYSTS: CVSI compared to CWBHF:
As of 17 FEB 2023:
https://stockanalysis.com/stocks/cvsi/ https://stockanalysis.com/stocks/cwbhf/
MULTIPLE ANALYSTS: CWBHF compared to CVSI:
As of 17 FEB 2023:
https://stockanalysis.com/stocks/cwbhf/ https://stockanalysis.com/stocks/cvsi/
Sorry for the belated reply
I'm posting on this board because my iHub membership does not allow "private" reply/send so I'll be " vague" in this message.
Additionally, I am severely limited in the number of messages I can post per day. Go figure.
Regarding "the biggest douche", I agree 100%. So I'll do what I can. I too have experienced the deletion problem you mentioned.
I CAN RECEIVE PRIVATE MESSAGES but can't send them, so if there's anything you want to tell me in this matter, feel free to private message me.
You have my TOTAL SYMPATHY !! LOL.
SERIOUSLY!Why should ANYONE INVEST in CV SCIENCES??
GIVEN:
1. Its PERFORMANCE as a STOCK:
but, MORE IMPORTANTLY,
2. Its PERFORMANCE as a BUSINESS:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=170657983
"The CBD gold rush is over" . . . for CV Sciences.
CV Sciences: A TEMPORAL PERSPECTIVE
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=170657983
Relationship between StanleyBrothersUSAHoldings and AJNABiosciences
I believe the relationship is that of "Incubator-to-StartUp" and NOT "Identity".
The role of Stanley Brothers USA Holdings as a "cannabis wellness incubator" was stated in the March 3, 2021 press release describing Charlotte's Web's Option Purchase Agreement with Stanley Brothers USA Holdings:
Time for a REALITY CHECK on CV Sciences:
CV Sciences' performance has been decaying for years:
"The CBD gold rush is over" . . . for CV Sciences.